Related references
Note: Only part of the references are listed.Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis
Jodi M. Lestner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp.
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
A. Espinel-Ingroff et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing
Cornelia Lass-Floerl et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Species Identification and Antifungal Susceptibility Patterns of Species Belonging to Aspergillus Section Nigri
Laura Alcazar-Fuoli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Trends in invasive fungal infections, with emphasis on invasive aspergillosis
Z. Erjavec et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic: Approaches in Deriving Breakpoints
A. Dalhoff et al.
INFECTION (2009)
Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
John W. Baddley et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus
Juan Luis Rodriguez-Tudela et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Aspergillus section fumigati: Antifungal susceptibility patterns and sequence-based identification
Laura Alcazar-Fuoli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Potential basis for amphotericin B resistance in Aspergillus terreus
Gerhard Blum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Factors associated with overall and attributable mortality in invasive aspergillosis
Yasmine Nivoix et al.
CLINICAL INFECTIOUS DISEASES (2008)
EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds - Subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST)
J. -L. Rodriquez Tudela et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Changing epidemiology of systemic fungal infections
M. Richardson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Recent advances and challenges in the treatment of invasive fungal infections
Pei-Lan Shao et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients
Penelope D. Barnes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Setting and revising antibacterial susceptibility breakpoints
John Turnidge et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
E. Chryssanthou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values
J Turnidge et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
International surveillance of Candida spp. and Aspergillus spp.:: Report from the SENTRY Antimicrobial Surveillance Program (2003)
Shawn A. Messer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Aspergillus ustus infections among transplant recipients
AA Panackal et al.
EMERGING INFECTIOUS DISEASES (2006)
Aspergillus lentulus sp nov., a new sibling species of A-fumigatus
SA Balajee et al.
EUKARYOTIC CELL (2005)
Analysis of the influence of Tween concentration, inoculum size, assay medium, and reading time on susceptibility testing of Aspergillus spp.
A Gomez-Lopez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection
WJ Steinbach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Experimental pulmonary aspergillosis due to Aspergillus terreus:: Pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B
TJ Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.:: NCCLS collaborative evaluation
A Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)